Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Werewolf Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +45 vs. Q1 2021
- Shares held
- 19.8M
- +19.8M vs. Q1 2021
- Total value
- $344.3M
- +$344.3M vs. Q1 2021
- New holders
- 45
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HOWL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $3.91M |
| Q1 2026 | 48 | $11.7M |
| Q4 2025 | 51 | $9.34M |
| Q3 2025 | 62 | $41.6M |
| Q2 2025 | 65 | $24.3M |
| Q1 2025 | 70 | $26.7M |
| Q4 2024 | 73 | $41.7M |
| Q3 2024 | 69 | $68.3M |
| Q2 2024 | 71 | $79.2M |
| Q1 2024 | 61 | $209.0M |
| Q4 2023 | 41 | $106.8M |
| Q3 2023 | 35 | $51.1M |
| Q2 2023 | 36 | $73.3M |
| Q1 2023 | 38 | $62.5M |
| Q4 2022 | 39 | $42.8M |
| Q3 2022 | 44 | $94.5M |
| Q2 2022 | 46 | $78.0M |
| Q1 2022 | 49 | $83.5M |
| Q4 2021 | 51 | $228.3M |
| Q3 2021 | 42 | $326.2M |
| Q2 2021 | 45 | $344.3M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Werewolf Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 52 | $1.00K | 0.00% | +52 | New |
| Financial Perspectives, Inc | 250 | $4.36K | 0.00% | +250 | New |
| Morgan Stanley | 267 | $5.00K | 0.00% | +267 | New |
| Bank of America Corp | 487 | $8.00K | 0.00% | +487 | New |
| Royal Bank of Canada | 519 | $9.00K | 0.00% | +519 | New |
| Ameritas Investment Partners, Inc. | 593 | $10.0K | 0.00% | +593 | New |
| Legal & General Group Plc | 736 | $13.0K | 0.00% | +736 | New |
| UBS Group AG | 1,000 | $17.0K | 0.00% | +1,000 | New |
| STRS Ohio | 1,800 | $31.0K | 0.00% | +1,800 | New |
| Citigroup Inc | 2,016 | $35.0K | 0.00% | +2,016 | New |
| American International Group, Inc. | 4,241 | $74.0K | 0.00% | +4,241 | New |
| Deutsche Bank AG | 4,492 | $78.0K | 0.00% | +4,492 | New |
| JPMorgan Chase & Co | 9,352 | $163.0K | 0.00% | +9,352 | New |
| Capstone Investment Advisors, LLC | 10,000 | $174.0K | 0.00% | +10,000 | New |
| California State Teachers Retirement System | 10,465 | $183.0K | 0.00% | +10,465 | New |
| Schonfeld Strategic Advisors LLC | 11,300 | $197.0K | 0.00% | +11,300 | New |
| Nuveen Asset Management, LLC | 12,001 | $209.0K | 0.00% | +12,001 | New |
| New York State Common Retirement Fund | 13,031 | $227.0K | 0.00% | +13,031 | New |
| Arena Capital Advisors, LLC- CA | 14,958 | $261.0K | 0.02% | +14,958 | New |
| Charles Schwab Investment Management Inc | 16,038 | $280.0K | 0.00% | +16,038 | New |
| Evercore Wealth Management, LLC | 21,500 | $375.0K | 0.01% | +21,500 | New |
| Bank of New York Mellon Corp | 22,213 | $387.0K | 0.00% | +22,213 | New |
| Aristides Capital LLC | 25,585 | $446.0K | 0.34% | +25,585 | New |
| Goldman Sachs Group Inc | 37,435 | $653.0K | 0.00% | +37,435 | New |
| Northern Trust Corp | 75,774 | $1.32M | 0.00% | +75,774 | New |
| State Street Corp | 78,237 | $1.36M | 0.00% | +78,237 | New |
| Caas Capital Management LP | 100,000 | $1.74M | 0.09% | +100,000 | New |
| Geode Capital Management, LLC | 108,178 | $1.89M | 0.00% | +108,178 | New |
| Vanguard Group Inc | 173,127 | $3.02M | 0.00% | +173,127 | New |
| Migdal Insurance & Financial Holdings Ltd. | 187,500 | $3.27M | 0.03% | +187,500 | New |
| Alyeska Investment Group, L.P. | 206,201 | $3.60M | 0.04% | +206,201 | New |
| Platinum Investment Management Ltd | 206,915 | $3.61M | 0.08% | +206,915 | New |
| Nicholas Investment Partners, LP | 294,654 | $5.14M | 0.32% | +294,654 | New |
| FMR LLC | 315,000 | $5.49M | 0.00% | +315,000 | New |
| BlackRock Inc. | 365,863 | $6.38M | 0.00% | +365,863 | New |
| PFM Health Sciences, LP | 400,000 | $6.98M | 0.22% | +400,000 | New |
| Soleus Capital Management, L.P. | 563,396 | $9.83M | 1.51% | +563,396 | New |
| DC Funds, LP | 589,102 | $10.3M | 48.81% | +589,102 | New |
| Avidity Partners Management LP | 650,265 | $11.3M | 0.31% | +650,265 | New |
| Sphera Funds Management Ltd. | 706,294 | $12.0M | 1.15% | +706,294 | New |
| Adage Capital Partners GP, L.L.C. | 1,000,597 | $17.4M | 0.03% | +1,000,597 | New |
| MPM Oncology Impact Management LP | 2,388,011 | $41.6M | 6.84% | +2,388,011 | New |
| Deerfield Management Company, L.P. (Series C) | 2,552,787 | $44.5M | 0.79% | +2,552,787 | New |
| MPM Asset Management LLC | 4,284,172 | $74.7M | 13.89% | +4,284,172 | New |
| Ra Capital Management, L.P. | 4,291,881 | $74.8M | 1.20% | +4,291,881 | New |